{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T04:40:26Z","timestamp":1739076026443,"version":"3.37.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,8]]},"DOI":"10.7759\/cureus.78752","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T04:25:11Z","timestamp":1739075111000},"source":"Crossref","is-referenced-by-count":0,"title":["Transthyretin Cardiac Amyloidosis in a Very Elderly Patient With a History of Inferior Myocardial Infarction: A Case Report"],"prefix":"10.7759","author":[{"given":"Satoshi","family":"Kurisu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2017.10.003","article-title":"Recent advances in diagnosis and treatment of cardiac amyloidosis","volume":"71","author":"Izumiya Y","year":"2018","unstructured":"Izumiya Y, Takashio S, Oda S, Yamashita Y, Tsujita K. Recent advances in diagnosis and treatment of cardiac amyloidosis. J Cardiol. 2018, 71:135-43. 10.1016\/j.jjcc.2017.10.003","journal-title":"J Cardiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0110","article-title":"JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis","volume":"84","author":"Kitaoka H","year":"2020","unstructured":"Kitaoka H, Izumi C, Izumiya Y, et al.. JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis. Circ J. 2020, 84:1610-71. 10.1253\/circj.CJ-20-0110","journal-title":"Circ J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association","volume":"142","author":"Kittleson MM","year":"2020","unstructured":"Kittleson MM, Maurer MS, Ambardekar AV, et al.. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2020, 142:e7-22. 10.1161\/CIR.0000000000000792","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13473","article-title":"Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag symptom clusters and diagnostic algorithm","volume":"8","author":"Inomata T","year":"2021","unstructured":"Inomata T, Tahara N, Nakamura K, et al.. Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag symptom clusters and diagnostic algorithm. ESC Heart Fail. 2021, 8:2647-59. 10.1002\/ehf2.13473","journal-title":"ESC Heart Fail"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03140-y","article-title":"Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients","volume":"23","author":"Hassan R","year":"2023","unstructured":"Hassan R, Miller RJ, Howlett JG, White JA, Fine NM. Prevalence, incidence and clinical outcomes of epicardial coronary artery disease among transthyretin amyloidosis cardiomyopathy patients. BMC Cardiovasc Disord. 2023, 23:124. 10.1186\/s12872-023-03140-y","journal-title":"BMC Cardiovasc Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis","volume":"114","author":"Cyrille NB","year":"2014","unstructured":"Cyrille NB, Goldsmith J, Alvarez J, Maurer MS. Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis. Am J Cardiol. 2014, 114:1089-93. 10.1016\/j.amjcard.2014.07.026","journal-title":"Am J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/anec.12018","article-title":"The findings of electrocardiography in patients with cardiac amyloidosis","volume":"18","author":"Cheng Z","year":"2013","unstructured":"Cheng Z, Zhu K, Tian Z, Zhao D, Cui Q, Fang Q. The findings of electrocardiography in patients with cardiac amyloidosis. Ann Noninvasive Electrocardiol. 2013, 18:157-62. 10.1111\/anec.12018","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2023.02.006","article-title":"Electrocardiographic features and rhythm disorders in cardiac amyloidosis","volume":"34","author":"Martini N","year":"2024","unstructured":"Martini N, Sinigiani G, De Michieli L, et al.. Electrocardiographic features and rhythm disorders in cardiac amyloidosis. Trends Cardiovasc Med. 2024, 34:257-64. 10.1016\/j.tcm.2023.02.006","journal-title":"Trends Cardiovasc Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1253\/jcj.64.421","article-title":"Time course of left ventricular remodeling after myocardial infarction: a two-dimensional echocardiographic study","volume":"64","author":"Sakai Y","year":"2000","unstructured":"Sakai Y, Tsunoda K, Ishibashi I, Miyazaki Y, Takahashi O, Masuda Y. Time course of left ventricular remodeling after myocardial infarction: a two-dimensional echocardiographic study. Jpn Circ J. 2000, 64:421-9. 10.1253\/jcj.64.421","journal-title":"Jpn Circ J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore JD","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, et al.. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016, 133:2404-12. 10.1161\/CIRCULATIONAHA.116.021612","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh SF","year":"2016","unstructured":"Nagueh SF, Smiseth OA, Appleton CP, et al.. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016, 29:277-314. 10.1016\/j.echo.2016.01.011","journal-title":"J Am Soc Echocardiogr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.63151","article-title":"Delayed diagnosis of cardiac amyloidosis masked by chronic coronary artery disease and ischemic cardiomyopathy: a case report of an overlooked and underdiagnosed etiology","volume":"16","author":"Rathore A","year":"2024","unstructured":"Rathore A, Tripathi V, Mathur P, Kadariya D. Delayed diagnosis of cardiac amyloidosis masked by chronic coronary artery disease and ischemic cardiomyopathy: a case report of an overlooked and underdiagnosed etiology. Cureus. 2024, 16:e63151. 10.7759\/cureus.63151","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43547","article-title":"Persistent heart failure despite medical therapy leading to a diagnosis of cardiac amyloidosis","volume":"15","author":"Maraj D","year":"2023","unstructured":"Maraj D, Ramanan S, Patel PM, Memon M, Hawes E. Persistent heart failure despite medical therapy leading to a diagnosis of cardiac amyloidosis. Cureus. 2023, 15:e43547. 10.7759\/cureus.43547","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg FL","year":"2012","unstructured":"Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012, 126:1286-300. 10.1161\/CIRCULATIONAHA.111.078915","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10123226","article-title":"Transthyretin cardiac amyloidosis: a cardio-orthopedic disease","volume":"10","author":"Perfetto F","year":"2022","unstructured":"Perfetto F, Zampieri M, Bandini G, et al.. Transthyretin cardiac amyloidosis: a cardio-orthopedic disease. Biomedicines. 2022, 10:3226. 10.3390\/biomedicines10123226","journal-title":"Biomedicines"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.75582","article-title":"Carpal tunnel syndrome as a potential indicator of cardiac amyloidosis: a systematic review and meta-analysis","volume":"16","author":"Elghouneimy MA","year":"2024","unstructured":"Elghouneimy MA, Bushara N, Abdelwahab OA, Makableh AA, Alnabwy DM, Diab RA. Carpal tunnel syndrome as a potential indicator of cardiac amyloidosis: a systematic review and meta-analysis. Cureus. 2024, 16:e75582. 10.7759\/cureus.75582","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano A","year":"2016","unstructured":"Castano A, Haq M, Narotsky DL, et al.. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol. 2016, 1:880-9. 10.1001\/jamacardio.2016.2839","journal-title":"JAMA Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.10.028","article-title":"Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement","volume":"95","author":"Murtagh B","year":"2005","unstructured":"Murtagh B, Hammill SC, Gertz MA, Kyle RA, Tajik AJ, Grogan M. Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement. Am J Cardiol. 2005, 95:535-7. 10.1016\/j.amjcard.2004.10.028","journal-title":"Am J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/338169-transthyretin-cardiac-amyloidosis-in-a-very-elderly-patient-with-a-history-of-inferior-myocardial-infarction-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T04:25:19Z","timestamp":1739075119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/338169-transthyretin-cardiac-amyloidosis-in-a-very-elderly-patient-with-a-history-of-inferior-myocardial-infarction-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,8]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.78752","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,8]]}}}